The financial world’s eyes turn to Monaco once again! On Thursday, June 12, the prestigious Sohn Monaco Investment Conference returns for its fifth edition at the Monaco Yacht Club, held under the High Patronage of H.S.H. Prince Albert II of Monaco. This highly anticipated event gathers Europe’s most prominent hedge fund managers to unveil their most compelling investment insights — all in crucial support of groundbreaking pediatric cancer research.
A global mission: From finance to hope
Established in 1995 to honor the memory of Ira Sohn and his brave fight against cancer, the Sohn Conference Foundation has grown into a formidable global force in both finance and philanthropy. Over the years, it has inspired over $95 million in charitable giving from the financial community, directly fueling breakthroughs in medical research, advanced equipment, and compassionate care for children battling cancer worldwide.
Today, Sohn Conferences are held in nine cities across five continents, uniting the global financial community around a singular, powerful cause: giving young cancer patients the chance not just to survive, but to truly thrive.
What to expect
At Sohn Monaco 2025, attendees will have the opportunity to gain unparalleled market perspectives and forward-thinking investment strategies, directly from some of the industry’s most influential hedge fund managers and alternative investors. Furthermore, the conference offers exceptional networking opportunities, allowing connections with leading investors, influential thought leaders, and esteemed peers in an inspiring and elegant setting, fostering invaluable professional relationships. All of this is underpinned by a deep sense of purpose-driven participation, as every single dollar — from registration fees to sponsorships — goes directly toward vital pediatric cancer research, offering tangible hope to children and their families worldwide.
Fueling vital research
The Sohn Monaco Investment Conference proudly supports leading institutions dedicated to combating pediatric cancer. Past beneficiaries have included:
- The Division of Pediatric Hematology-Oncology, University Hospital of Nice
- The French National Institute of Health and Medical Research (INSERM)
- The Innovative Therapies for Children with Cancer (ITCC), Paris
- The Monaco Scientific Center
This year’s pivotal event is skillfully chaired by Justin Hilbert and Florence Tournier, whose key roles have been instrumental in attracting some of the most innovative and influential figures in European finance to Monaco, ensuring a impactful and successful conference.
